3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
92
Lymphoma, Non-Hodgkin
91
Precursor Cell Lymphoblastic Leukemia-Lymphoma
85
Leukemia, Lymphocytic, Chronic, B-Cell
74
Lymphoma, Follicular
58
Lymphoma, Large B-Cell, Diffuse
57
Burkitt Lymphoma
44
Hodgkin Disease
43
Recurrence
39
Lymphoma, B-Cell
38
Multiple Myeloma
37
Lymphoma, Mantle-Cell
35
Leukemia, Myeloid, Acute
35
Leukemia
34
Myelodysplastic Syndromes
25
Hematologic Neoplasms
25
Neoplasms
23
Lymphoma, B-Cell, Marginal Zone
19
Waldenstrom Macroglobulinemia
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Leukemia, B-Cell
16
Sarcoma
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, T-Cell, Peripheral
11
Lymphoma, Large-Cell, Anaplastic
11
Neuroblastoma
10
Lymphoma, T-Cell
10
Leukemia, Biphenotypic, Acute
10
Glioma
10
Osteosarcoma
9
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraparesis, Tropical Spastic
×
Lymphoid
×
30 days
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled